PeopleBio, Inc. (KOSDAQ:304840)
South Korea flag South Korea · Delayed Price · Currency is KRW
561.00
-9.00 (-1.58%)
At close: Jul 31, 2026

PeopleBio Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
3,8372,8512,5314,4534,445577.08
Other Revenue
00-0--0
3,8372,8512,5314,4534,445577.08
Revenue Growth
119.84%12.64%-43.17%0.18%670.22%13.63%
Cost of Revenue
3,1343,3272,1003,0773,1151,365
Gross Profit
702.53-476.51430.91,3761,330-787.66
Selling, General & Admin
5,8045,3595,96810,3708,6923,728
Research & Development
938.061,7502,2885,1603,3902,119
Amortization of Goodwill & Intangibles
63.596.4627.54358.16380.16177.95
Other Operating Expenses
230.56215.76250.15277.62176.91130.17
Operating Expenses
11,47311,7209,11616,62313,0276,448
Operating Income
-10,771-12,197-8,685-15,248-11,697-7,236
Interest Expense
-3,810-2,700-943.28-2,399-2,979-1,134
Interest & Investment Income
167.85272.06236.52376.99533.4998.51
Earnings From Equity Investments
-442.79-901.6-947.05-934.89-835.96-380.5
Currency Exchange Gain (Loss)
-11.39-14.892.54-34.8715.67-1.9
Other Non Operating Income (Expenses)
2,0902,7681,5862,277-58.183,706
EBT Excluding Unusual Items
-12,777-12,773-8,751-15,962-15,020-4,947
Gain (Loss) on Sale of Investments
305.24418.76-433.8-395.43--
Gain (Loss) on Sale of Assets
-0.62---17.655.17
Other Unusual Items
-191.36-191.3620.68-1,025--
Pretax Income
-12,664-12,545-9,164-17,382-15,003-4,942
Earnings From Continuing Operations
-12,664-12,545-9,164-17,382-15,003-4,942
Earnings From Discontinued Operations
-3,615-4,393-3,009---
Net Income to Company
-16,279-16,939-12,173-17,382-15,003-4,942
Minority Interest in Earnings
909.661,2251,2601,348699.7244.85
Net Income
-15,369-15,714-10,913-16,035-14,303-4,697
Net Income to Common
-15,722-15,714-10,913-16,035-14,303-4,697
Net Income Growth
------
Shares Outstanding (Basic)
232222171514
Shares Outstanding (Diluted)
232222171516
Shares Change
3.83%0.10%31.16%13.30%-8.80%32.17%
EPS (Basic)
-696.00-722.13-502.00-967.45-977.75-340.35
EPS (Diluted)
-696.76-722.13-502.00-967.45-978.00-457.08
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-9,930-5,396-10,990-17,001-15,242-8,188
Free Cash Flow Per Share
-439.60-247.98-505.52-1025.76-1041.91-510.46
Gross Margin
18.31%-16.72%17.03%30.90%29.92%-136.49%
Operating Margin
-280.71%-427.87%-343.21%-342.42%-263.16%-1253.81%
Profit Margin
-409.75%-551.26%-431.25%-360.10%-321.79%-813.94%
Free Cash Flow Margin
-258.81%-189.30%-434.27%-381.80%-342.91%-1418.84%
EBITDA
-9,813-10,450-6,993-13,683-10,415-6,501
EBITDA Margin
-255.74%--276.35%--234.32%-
D&A For EBITDA
957.871,7471,6921,5651,282734.08
EBIT
-10,771-12,197-8,685-15,248-11,697-7,236
EBIT Margin
-280.71%----263.16%-
Advertising Expenses
-174.78181.612,9052,879223.74